This week’s UK tech funding deals include inflammatory disease treatment developer Maxion Therapeutics, surgical device firm Eventum Orthapaedics and more.
UKTN tracked £67m worth of UK tech investment this week (17 March to 21 March), a 9% week-on-week decrease across five funding rounds.
Here’s your weekly roundup of UK tech startup funding deals.
Maxion Therapeutics – £58m
Sector: Health tech
HQ: Cambridge
Round: Series A
Investors: General Catalyst, British Patient Capital, Solasta Ventures and Eli Lilly and Company
Founded in 2020, Maxion Therapeutics is developing treatments for inflammatory diseases
Read more
Eventum Orthapaedics – £3.8m
Sector: Health tech
HQ: Leeds
Round: Early VC
Investors: Mercia Asset Management
Founded in 2020, Eventum Orthapaedics has developed the QuadSense device to provide real time data for surgeons.
Read more
EDX Medical – £3m
Sector: Health tech…
